Tag: iShares U.S. Pharmaceuticals ETF

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi